Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001144204-13-028768
Filing Date
2013-05-14
Accepted
2013-05-14 16:46:02
Documents
10
Period of Report
2013-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q v344203_10q.htm 10-Q 211569
2 EX-31.1 v344203_ex31-1.htm EX-31.1 8098
3 EX-31.2 v344203_ex31-2.htm EX-31.2 8152
4 EX-32 v344203_ex32.htm EX-32 5068
  Complete submission text file 0001144204-13-028768.txt   2432632

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT ovit-20130331.xml EX-101.INS 218189
6 XBRL TAXONOMY EXTENSION SCHEMA ovit-20130331.xsd EX-101.SCH 38625
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE ovit-20130331_cal.xml EX-101.CAL 23795
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE ovit-20130331_def.xml EX-101.DEF 167196
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE ovit-20130331_lab.xml EX-101.LAB 269434
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE ovit-20130331_pre.xml EX-101.PRE 203208
Mailing Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245
Business Address 14785 OMICRON DRIVE SUITE 104 SAN ANTONIO TX 78245 210 677 6000
ONCOVISTA INNOVATIVE THERAPIES, INC (Filer) CIK: 0001094847 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-28347 | Film No.: 13842209
SIC: 2834 Pharmaceutical Preparations